Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2831)
All Articles published online
|
Jan 21, 2009 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gelu-Simeon M, Burlaud A, Young J, Pelletier G, Buffet C. Evolution and predictive factors of thyroid disorder due to interferon alpha in the treatment of hepatitis C. World J Gastroenterol 2009; 15(3): 328-333 [PMID: 19140232 DOI: 10.3748/wjg.15.328] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i3/328.htm |
| Number | Citing Articles |
| 1 |
Zehui Yan, Ke Fan, Yi Fan, Xiaohong Wang, Qing Mao, Guohong Deng, Yuming Wang. Thyroid Dysfunction in Chinese Patients with Chronic Hepatitis C Treated with Interferon Alpha: Incidence, Long-Term Outcome and Predictive Factors. Hepatitis Monthly 2012; 12(9) doi: 10.5812/hepatmon.6390
|
| 2 |
J.-G. Marchand, G. Russ, E. Ghanassia, J. Tramalloni, H. Monpeyssen, P.-Y. Marcy. Imagerie des dysthyroïdies. Journal d'imagerie diagnostique et interventionnelle 2022; 5(3): 141 doi: 10.1016/j.jidi.2021.12.006
|
| 3 |
Jennifer S. Mammen, Sharon R. Ghazarian, Erik Pulkstenis, G. Mani Subramanian, Antony Rosen, Paul W. Ladenson. Phenotypes of Interferon-α-Induced Thyroid Dysfunction among Patients Treated for Hepatitis C Are Associated with Pretreatment Serum TSH and Female Sex. The Journal of Clinical Endocrinology & Metabolism 2012; 97(9): 3270 doi: 10.1210/jc.2012-1026
|
| 4 |
Jennifer S. Mammen, Sharon R. Ghazarian, Antony Rosen, Paul W. Ladenson. Patterns of Interferon-Alpha–Induced Thyroid Dysfunction Vary with Ethnicity, Sex, Smoking Status, and Pretreatment Thyrotropin in an International Cohort of Patients Treated for Hepatitis C. Thyroid 2013; 23(9): 1151 doi: 10.1089/thy.2012.0565
|
| 5 |
Linghuan Wang, Binqi Li, He Zhao, Peixin Wu, Qingzhen Wu, Kang Chen, Yiming Mu. A systematic review and meta-analysis of endocrine-related adverse events associated with interferon. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.949003
|
| 6 |
Seán J. Costelloe, Nancy Wassef, Josephine Schulz, Tina Vaghijiani, Catherine Morris, Stephen Whiting, Michael Thomas, Geoffrey Dusheiko, Michael Jacobs, Mark P. J. Vanderpump. Thyroid dysfunction in a UK hepatitis C population treated with interferon‐α and ribavirin combination therapy. Clinical Endocrinology 2010; 73(2): 249 doi: 10.1111/j.1365-2265.2010.03785.x
|
| 7 |
Huy A. Tran, Tracey L. Jones, Elizabeth A. Ianna, Aidan Foy, Glenn E.M. Reeves. Thyroid Disease in Chronic Hepatitis C Infection Treated With Combination Interferon-a and Ribavirin: Management Strategies and Future Perspective. Endocrine Practice 2013; 19(2): 292 doi: 10.4158/EP12195.RA
|
| 8 |
Hai Fang, Julian Gough. A disease-drug-phenotype matrix inferred by walking on a functional domain network. Molecular BioSystems 2013; 9(7): 1686 doi: 10.1039/c3mb25495j
|
| 9 |
Ren-Wen Zhang, Cui-Ping Shao, Na Huo, Min-Ran Li, Hong-Li Xi, Min Yu, Xiao-Yuan Xu. Thyroid dysfunction in Chinese hepatitis C patients: Prevalence and correlation with TPOAb and CXCL10. World Journal of Gastroenterology 2015; 21(33): 9765-9773 doi: 10.3748/wjg.v21.i33.9765
|
| 10 |
Shigeki Morita, Takuya Honda, Fumihiro Mawatari, Shotaro Tsuruta, Ryuji Furukawa. A case of Graves' disease following painless thyroiditis induced by pegylated-interferon and ribavirin therapy to a patient with chronic hepatitis C. Kanzo 2010; 51(6): 300 doi: 10.2957/kanzo.51.300
|
| 11 |
Frederik A. Verburg, Markus Luster, Cristina Cupini, Luca Chiovato, Leonidas Duntas, Rossella Elisei, Ulla Feldt-Rasmussen, Harald Rimmele, Ettore Seregni, Johannes W.A. Smit, Christian Theimer, Luca Giovanella. Implications of Thyroglobulin Antibody Positivity in Patients with Differentiated Thyroid Cancer: A Clinical Position Statement. Thyroid 2013; 23(10): 1211 doi: 10.1089/thy.2012.0606
|
| 12 |
Jean P. Molleston, William Mellman, Michael R. Narkewicz, William F. Balistreri, Regino P. Gonzalez‐Peralta, Maureen M. Jonas, Steven J. Lobritto, Parvathi Mohan, Karen F. Murray, Dolores Njoku, Philip Rosenthal, Bruce A. Barton, Monica V. Talor, Irene Cheng, Kathleen B. Schwarz, Barbara A. Haber. Autoantibodies and Autoimmune Disease During Treatment of Children With Chronic Hepatitis C. Journal of Pediatric Gastroenterology and Nutrition 2013; 56(3): 304 doi: 10.1097/MPG.0b013e3182774cae
|
| 13 |
Amina Nadeem, Muhammad Aslam. Association of Interferon-Alpha and Ribavirin-Induced Thyroid Dysfunction with Severity of Disease and Response to Treatment in Pakistani Asian Patients of Chronic Hepatitis C. Hepatitis Research and Treatment 2012; 2012: 1 doi: 10.1155/2012/864315
|
| 14 |
Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 2009; 16(5): 401 doi: 10.1097/MED.0b013e32833118e2
|
| 15 |
Wenxue Zhao, Fanpu Ji, Shanshan Yu, Zongfang Li, Hong Deng. Dilated cardiomyopathy and hypothyroidism associated with pegylated interferon and ribavirin treatment for chronic hepatitis C: case report and literature review. The Brazilian Journal of Infectious Diseases 2014; 18(1): 110 doi: 10.1016/j.bjid.2013.05.014
|
| 16 |
Braira Wahid, Muhammad Waqar, Nouman Rasool, Muhammad Wasim, Ifrah Khalid, Muhammad Idrees. Prevalence of thyroid stimulating hormone dysfunction among sofosbuvir‐treated HCV‐infected patients: A real‐world clinical experience. Journal of Medical Virology 2019; 91(3): 514 doi: 10.1002/jmv.25319
|
| 17 |
Huy A. Tran, Glenn E. M. Reeves, Paul M. Yen. The Spectrum of Autoimmune Thyroid Disease in the Short to Medium Term Following Interferon‐α Therapy for Chronic Hepatitis C. International Journal of Endocrinology 2009; 2009(1) doi: 10.1155/2009/241786
|
| 18 |
Debora Lucia Seguro Danilovic, Maria Cassia Mendes-Correa, Maria Cristina Chammas, Heverton Zambrini, Suemi Marui. Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin. Clinics 2011; 66(10): 1757 doi: 10.1590/S1807-59322011001000014
|